Publications Repository

Publications Repository

View item 
  •   Home
  • ICR Divisions
  • Other ICR Research
  • View item
  • Home
  • ICR Divisions
  • Other ICR Research
  • View item
JavaScript is disabled for your browser. Some features of this site may not work without it.

UK 2022 Consensus on Normal Tissue Dose-Volume Constraints for Oligometastatic, Primary Lung and Hepatocellular Carcinoma Stereotactic Ablative Radiotherapy.

Thumbnail
View/Open
Accepted version (937.6Kb)
ICR Author
Tree, Alison
Author
Diez, P
Hanna, GG
Aitken, KL
van As, N
Carver, A
Colaco, RJ
Conibear, J
Dunne, EM
Eaton, DJ
Franks, KN
Good, JS
Harrow, S
Hatfield, P
Hawkins, MA
Jain, S
McDonald, F
Patel, R
Rackley, T
Sanghera, P
Tree, A
Murray, L
Show allShow less
Type
Journal Article
Metadata
Show full item record
Abstract
The use of stereotactic ablative radiotherapy (SABR) in the UK has expanded over the past decade, in part as the result of several UK clinical trials and a recent NHS England Commissioning through Evaluation programme. A UK SABR Consortium consensus for normal tissue constraints for SABR was published in 2017, based on the existing literature at the time. The published literature regarding SABR has increased in volume over the past 5 years and multiple UK centres are currently working to develop new SABR services. A review and update of the previous consensus is therefore appropriate and timely. It is hoped that this document will provide a useful resource to facilitate safe and consistent SABR practice.
URI
https://repository.icr.ac.uk/handle/internal/5165
DOI
https://doi.org/10.1016/j.clon.2022.02.010
https://doi.org/10.1016/j.clon.2022.02.010
 
Collections
  • Other ICR Research
Subject
Lung
Humans
Carcinoma, Hepatocellular
Liver Neoplasms
Lung Neoplasms
Radiosurgery
Consensus
England
Language
eng
Date accepted
2022-02-14
Citation
Clinical oncology (Royal College of Radiologists (Great Britain)), 2022, 34 (5), pp. 288 - 300

Browse

All of ICR repositoryICR DivisionsBy issue dateAuthorsTitlesPublication TypesThis collectionBy issue dateAuthorsTitlesPublication Types
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.